Free tool
Stocks listed on NYSE
We cover 42 companies listed on NYSE. The median market value in the group is $4.66B. Across the group, the median move over the past trading day is −0.06%. 85% of the 41 with a 200-day average trade above it. Price change over the past year runs from −24.0% to +131.7% across the middle 80 percent of the group, with a median of +28.0%.
Other lists in this group
Table
42 of 1,978 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | $1.06T | Mega cap | +62.80% |
| JNJ | Johnson & Johnson | $658.24B | Mega cap | +55.40% |
| ABBV | AbbVie Inc. | $469.68B | Mega cap | +29.36% |
| MRK | Merck & Co., Inc. | $377.72B | Mega cap | +86.85% |
| NVS | Novartis AG | $299.44B | Mega cap | +27.93% |
| AZN | AstraZeneca PLC | $263.12B | Mega cap | +5.09% |
| TMO | Thermo Fisher Scientific Inc. | $234.31B | Mega cap | +30.17% |
| NVO | Novo Nordisk A/S | $208.63B | Mega cap | −13.32% |
| AVTR | Avantor, Inc. | $9.81B | Mid cap | +9.93% |
| BIO-B | Bio-Rad Laboratories, Inc. | $9.77B | Mid cap | +47.78% |
| OSCR | Oscar Health, Inc. | $9.55B | Mid cap | +83.55% |
| QGEN | Qiagen N.V. | $9.01B | Mid cap | −9.65% |
| ATR | AptarGroup, Inc. | $8.60B | Mid cap | −1.89% |
| HNGE | Hinge Health, Inc. | $7.25B | Mid cap | +56.66% |
| CHE | Chemed Corporation | $7.11B | Mid cap | +20.79% |
| PACS | PACS Group, Inc. | $7.03B | Mid cap | +274.28% |
| HIMS | Hims & Hers Health, Inc. | $6.96B | Mid cap | −32.22% |
| BLCO | Bausch + Lomb Corporation | $6.16B | Mid cap | +18.56% |
| STVN | Stevanato Group S.p.A. | $6.11B | Mid cap | −0.09% |
| TFX | Teleflex Incorporated | $5.88B | Mid cap | +8.06% |
| HAE | Haemonetics Corporation | $4.85B | Mid cap | +93.71% |
| NVST | Envista Holdings Corporation | $4.47B | Mid cap | +30.89% |
| CON | Concentra Group Holdings Parent, Inc. | $4.44B | Mid cap | +50.93% |
| DOCS | Doximity, Inc. | $4.41B | Mid cap | −63.61% |
| MANE | Veradermics, Incorporated | $4.29B | Mid cap | +172.32% |
| ITGR | Integer Holdings Corporation | $4.25B | Mid cap | +15.84% |
| RCUS | Arcus Biosciences, Inc. | $3.92B | Mid cap | +191.29% |
| OGN | Organon & Co. | $3.62B | Mid cap | +50.67% |
| WRBY | Warby Parker Inc. | $3.15B | Mid cap | −3.96% |
| BKD | Brookdale Senior Living Inc. | $2.91B | Mid cap | +55.61% |
| BHVN | Biohaven Ltd. | $2.56B | Mid cap | +8.65% |
| PBH | Prestige Consumer Healthcare Inc. | $2.47B | Mid cap | −22.12% |
| NUVB | Nuvation Bio Inc. | $2.44B | Mid cap | +135.93% |
| BHC | Bausch Health Companies Inc. | $2.43B | Mid cap | −10.45% |
| GRDN | Guardian Pharmacy Services, Inc. | $2.36B | Mid cap | +45.50% |
| BFLY | Butterfly Network, Inc. | $2.30B | Mid cap | +450.32% |
| MD | Pediatrix Medical Group, Inc. | $2.19B | Mid cap | +56.87% |
| PRGO | Perrigo Company plc | $2.05B | Mid cap | −36.05% |
| SEM | Select Medical Holdings Corp | $2.05B | Mid cap | +28.14% |
| ACH | Accendra Health, Inc. | $93.82M | Micro cap | −75.05% |
| ANVS | Annovis Bio, Inc. | $75.84M | Micro cap | −24.26% |
| CCM | Concord Medical Services Holdings Limited | $21.49M | Micro cap | −10.47% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.